MedPath

Cutia Therapeutics (Shanghai) Co., Ltd

🇨🇳China
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

1

Active:0
Completed:1

Trial Phases

1 Phases

Phase 3:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials

Phase 3
1 (100.0%)

To Evaluate the Efficacy and Safety of Minocycline Hydrochloride Foam in the Treatment of Moderate-to-severe Acne Vulgaris

Phase 3
Completed
Conditions
Acne Vulgaris
Interventions
First Posted Date
2021-07-14
Last Posted Date
2023-09-28
Lead Sponsor
Cutia Therapeutics (Shanghai) Co., Ltd
Target Recruit Count
372
Registration Number
NCT04960930
Locations
🇨🇳

Beijing Friendship Hospital, Capital Medical University, Beijing, Beijing, China

🇨🇳

Xuanwu Hospital Capital Medical University, Beijing, Beijing, China

🇨🇳

Peking University Shougang Hospital, Beijing, Beijing, China

and more 26 locations

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.